Top Abstract Purchase Related
Home
>
Node
>
Subnode

Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005

Sunthornchart, S.; Linkins, R.W.; Natephisarnwanish, V.; Levine, W.C.; Maneesinthu, K.; Lolekha, R.; Tappero, J.W.; Trirat, N.; Muktier, S.; Chancharastong, P.; Fox, K.; Donchalermpak, S.; Vitek, C.; Supawitkul, S.

Addiction 103(10): 1687-1695

2008

ISSN/ISBN: 1360-0443
PMID: 18705685
DOI: 10.1111/j.1360-0443.2008.02303.x
Document Number: 203375
To estimate the prevalence of hepatitis B virus (HBV), tetanus, hepatitis A virus (HAV) and human immunodeficiency virus (HIV) in injecting drug users (IDUs), risk factors associated with infection and the feasibility of HBV vaccine delivery in HBV seronegatives. Cross-sectional seroprevalence survey of 1535 IDUs recruited from 17 Bangkok Metropolitan Administration (BMA) methadone clinics and HBV vaccination of seronegatives. Prevalence of antibody to HBV, tetanus, HAV and HIV was 87.8%, 68.1%, 60.2% and 35.9%, respectively. Prevalence of HBV and HAV increased with increasing age; prevalence of tetanus decreased with increasing age. Being HIV seropositive was related inversely to income and being tetanus seronegative. Of the 189 HBV seronegative IDUs, 81.0% completed the vaccine series. IDUs with HIV had a 6.5-fold odds of vaccine non-response. These data underscore the need for, and feasibility of, vaccine delivery in this population and support targeting efforts at high-risk age groups.

Document emailed within 0-6 h
Secure & encrypted payments

Devi, K.S.; Singh, N.B.; Singh, H.L.; Singh, Y.M. 2009: Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users Journal of the Indian Medical Association 107(3): 144; 146-147
Gyarmathy, V.A.; Rácz, J.óz. 2011: Human immunodeficiency virus (HIV) and Hepatitis C virus (HCV) testing among injecting drug users Orvosi Hetilap 152(4): 124-130
Suntharasamai, P.; Martin, M.; Vanichseni, S.; van Griensven, F.; Mock, P.A.; Pitisuttithum, P.; Tappero, J.W.; Sangkum, U.; Kitayaporn, D.; Gurwith, M.; Choopanya, K.; Choopanya, K.; Vanichseni, S.; Prasittipol, B.; Srisuwanvilai, L-Ong.; Subhachaturas, W.; Sangkum, U.; Bussaratid, V.; Kaewkungwal, J.; Kitayaporn, D.; Migasena, S.; Phonrat, B.; Pitisuttithum, P.; Pungpak, S.; Suntharasamai, P.; Chaowanachan, T.; Cherdtrakulkiat, T.; Kittikraisak, W.; Leelawiwat, W.; Martin, M.; McNicholl, J.; Na-Pompet, S.; Sinthuwattanawibul, C.; Tappero, J.W.; van Grie 2009: Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003 Addiction 104(2): 235-242
Roux, P.; Fugon, L.; Winnock, M.; Salmon-Céron, D.; Lacombe, K.; Sogni, P.; Spire, B.; Dabis, F.ço.; Carrieri, M.P. 2012: Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users Addiction 107(1): 152-159
Nasir, A.; Todd, C.S.; Stanekzai, M.R.; Bautista, C.T.; Botros, B.A.; Scott, P.T.; Strathdee, S.A.; Tjaden, J. 2011: Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities International Journal on Drug Policy 22(2): 145-152
Han, M.; Wang, Y.-l.; Wang, M.-j.; Zhou, Q.-h.; Jiang, Y. 2007: Application of BED-CEIA to estimate the human immunodeficiency virus prevalence among injecting drug users in Chongqing municipality Zhonghua Liu Xing Bing Xue Za Zhi 28(11): 1077-1080
Freeman, A.J.; Zekry, A.; Whybin, L.R.; Harvey, C.E.; van Beek, I.A.; de Kantzow, S.L.; Rawlinson, W.D.; Boughton, C.R.; Robertson, P.W.; Marinos, G.; Lloyd, A.R. 2000: Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s Medical Journal of Australia 172(12): 588-591
Wu, N.; Li, D.; Zhu, B.; Zou, W. 2003: Preliminary research on the co-infection of human immunodeficiency virus and hepatitis virus in intravenous drug users Chinese Medical Journal 116(9): 1318-1320
Choopanya, K.; Martin, M.; Suntharasamai, P.; Sangkum, U.; Mock, P.A.; Leethochawalit, M.; Chiamwongpaet, S.; Kitisin, P.; Natrujirote, P.; Kittimunkong, S.; Chuachoowong, R.; Gvetadze, R.J.; McNicholl, J.M.; Paxton, L.A.; Curlin, M.E.; Hendrix, C.W.; Vanichseni, S.; Choopanya, K.; Ayudhya, S.S.N.; Chiamwongpaet, S.; Kaewnil, K.; Kitisin, P.; Kukavejworakit, M.; Leethochawalit, M.; Natrujirote, P.; Simakajorn, S.; Subhachaturas, W.; Vanichseni, S.; Prasittipol, B.; Sangkum, U.; Suntharasamai, P.; Anekvorapong, R.; Khoomphong, C.; Koocharoenprasit, S.; Manomaipiboon, P.; Manotham, S.; Saicheua, P.; Sonthikaew, S.; Srisuwanvilai, L.-O.; Tanariyakul, S.; Thongsari, M.; Wattana, W.; Yongvanitjit, K.; Angwandee, S.; Kittimunkong, S.; Aueaksorn,; 2013: Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial Lancet 381(9883): 2083-2090
Solomon, S.S.; Celentano, D.D.; Srikrishnan, A.K.; Vasudevan, C.K.; Murugavel, K.G.; Iqbal, S.H.; Anand, S.; Kumar, M.S.; Latkin, C.; Solomon, S.; Mehta, S.H. 2010: Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India American Journal of Epidemiology 172(11): 1259-1267
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354
Kazi, A.M.; Shah, S.A.; Jenkins, C.A.; Shepherd, B.E.; Vermund, S.H. 2010: Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 14(Suppl 3): E60-E66
Calderón, G.M.; González-Velázquez, F.; González-Bonilla, C.R.; Novelo-Garza, B.ár.; Terrazas, J.J.; Martínez-Rodríguez, M.L.; Cortés-Márquez, S.R.; Blanco-Flores, J.P.; Rodríguez-Rodríguez, A.; Del Campo, M.A.; Cortés-Gómez, R.; Mejía-Bocanegra, M.G. 2009: Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico Transfusion 49(10): 2200-2207
Budhachandra, Y.; Ramesh, K.; Sumitra, G. 2007: Personality profile among Human Immunodeficiency Virus (HIV) positives and Acquired Immunodeficiency Syndrome (AIDS) patients of injecting drug users Kathmandu University Medical Journal 5(1): 38-41
Chung, D.C.; Ko, Y.C.; Chen, C.J.; Chen, E.R.; Wu, C.C.; Wu, P.S. 1989: Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan Journal of Medical Virology 28(4): 215-218
Iroezindu, M.O.; Daniyam, C.A.; Agbaji, O.O.; Isa, E.S.; Okeke, E.N.; Imade, G.E. 2013: Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria Journal of Infection in Developing Countries 7(12): 951-959
Vanichseni, S.; Des Jurlais, D.C.; Tappero, J.W.; Choopanya, K.; Mock, P.A.; Kitayaporn, D.; Sangkhum, U.; Prasithiphol, B.; Hu, D.J.; Van Griensven, F.; Mastro, T.D. 2004: Sexual risk reduction in a Cohort of injecting drug users in Bangkok, Thailand Journal of Acquired Immune Deficiency Syndromes (1999) 37(1): 1170-1179
Vanichseni, S.; Des Jarlais, D.C.; Choopanya, K.; Mock, P.A.; Kitayaporn, D.; Sangkhum, U.; Prasithiphol, B.; Hu, D.J.; van Griensven, F.; Mastro, T.D.; Tappero, J.W. 2004: Sexual risk reduction in a cohort of injecting drug users in Bangkok, Thailand Journal of Acquired Immune Deficiency Syndromes 37(1): 1170-1179
Liang, S.H.; Lo, Y.-C.; Lin, H.-H.; Chang, S.-Y.; Chen, M.-Y.; Hsieh, S.-M.; Sheng, W.-H.; Sun, H.-Y.; Hung, C.-C.; Chang, S.-C. 2008: Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital Journal of Microbiology Immunology and Infection 41(3): 200-208
Nelwan, E.J.; Van Crevel, R.; Alisjahbana, B.; Indrati, A.K.; Dwiyana, R.F.; Nuralam, N.; Pohan, H.T.; Jaya, I.; Meheus, A.; Van Der Ven, A. 2010: Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening Tropical Medicine and International Health: Tm and Ih 15(12): 1491-1498